SOLIGENIX, INC. Acquisitions, Net of Cash Acquired
SOLIGENIX, INC. (SNGX) reported Acquisitions, Net of Cash Acquired of $250.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2022-05-13
- SOLIGENIX, INC. payments to acquire businesses, net of cash acquired for fiscal 2014 was $250.00K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 0 month | Payments to Acquire Businesses, Net of Cash Acquired 0 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 1 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2014-12-31 | $250.00K 10-K · filed 2015-03-25 | |||
| 2014-09-30 | $275.00K 10-Q · filed 2022-05-13 | |||
| 2014-09-03 | $275.00K 10-K · filed 2022-03-29 | $250.00K 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |